Literature DB >> 28626214

Growth hormone-releasing hormone is produced by adipocytes and regulates lipolysis through growth hormone receptor.

F Rodríguez-Pacheco1, C Gutierrez-Repiso1, S García-Serrano1,2, A Ho-Plagaro3, J M Gómez-Zumaquero4, S Valdes1,2, M Gonzalo1, J Rivas-Becerra5, C Montiel-Casado5, G Rojo-Martínez1,2, E García-Escobar1,2, E García-Fuentes3,6.   

Abstract

BACKGROUND: Growth hormone-releasing hormone (GHRH) has a crucial role in growth hormone (GH) secretion, but little is known about its production by adipocytes and its involvement in adipocyte metabolism.
OBJECTIVES: To determine whether GHRH and its receptor (GHRH-R) are present in human adipocytes and to study their levels in obesity. Also, to analyze the effects of GHRH on human adipocyte differentiation and lipolysis.
METHODS: GHRH/GHRH-R and GH/GH-R mRNA expression levels were analyzed in human mature adipocytes from non-obese and morbidly obese subjects. Human mesenchymal stem cells (HMSC) were differentiated to adipocytes with GHRH (10-14-10-8 M). Adipocyte differentiation, lipolysis and gene expression were measured and the effect of GH-R silencing was determined.
RESULTS: Mature adipocytes from morbidly obese subjects showed a higher expression of GHRH and GH-R, and a lower expression of GHRH-R and GH than non-obese subjects (P<0.05). A total of 10-14-10-10 M GHRH induced an inhibition of lipid accumulation and PPAR-γ expression (P<0.05), and an increase in glycerol release and HSL expression (P<0.05) in human differentiated adipocytes. A total of 10-12-10-8 M GHRH decreased GHRH-R expression in human differentiated adipocytes (P<0.05). A total of 10-10-10-8 M GHRH increased GH and GH-R expression in human differentiated adipocytes (P<0.05). The effects of GHRH at 10-10 M on adipocyte differentiation and lipolysis were blocked when GH-R expression was silenced.
CONCLUSIONS: GHRH and GHRH-R are expressed in human adipocytes and are negatively associated. GHRH at low doses may exert an anti-obesity effect by inhibiting HMSC differentiation in adipocytes and by increasing adipocyte lipolysis in an autocrine or paracrine pathway. These effects are mediated by GH and GH-R.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28626214     DOI: 10.1038/ijo.2017.145

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  51 in total

1.  Thigh intermuscular fat is inversely associated with spontaneous GH release in post-menopausal women with abdominal obesity.

Authors:  Celina Franco; Johannes D Veldhuis; Ali Iranmanesh; John Brandberg; Lars Lönn; Björn Andersson; Bengt-Ake Bengtsson; Johan Svensson; Gudmundur Johannsson
Journal:  Eur J Endocrinol       Date:  2006-08       Impact factor: 6.664

2.  Homologous down-regulation of growth hormone-releasing hormone receptor messenger ribonucleic acid levels.

Authors:  G Aleppo; S F Moskal; P A De Grandis; R D Kineman; L A Frohman
Journal:  Endocrinology       Date:  1997-03       Impact factor: 4.736

3.  GH action influences adipogenesis of mouse adipose tissue-derived mesenchymal stem cells.

Authors:  Nicoleta C Olarescu; Darlene E Berryman; Lara A Householder; Ellen R Lubbers; Edward O List; Fabian Benencia; John J Kopchick; Jens Bollerslev
Journal:  J Endocrinol       Date:  2015-05-05       Impact factor: 4.286

4.  The obese healthy paradox: is inflammation the answer?

Authors:  Nuria Barbarroja; Rosario López-Pedrera; Maria Dolores Mayas; Eduardo García-Fuentes; Lourdes Garrido-Sánchez; M Macías-González; Rajaa El Bekay; Antonio Vidal-Puig; Francisco J Tinahones
Journal:  Biochem J       Date:  2010-08-15       Impact factor: 3.857

5.  Expression of growth hormone-releasing hormone (GHRH) and splice variant of GHRH receptors in normal mouse tissues.

Authors:  C Christodoulou; A V Schally; I Chatzistamou; A Kondi-Pafiti; K Lamnissou; S Kouloheri; A Kalofoutis; H Kiaris
Journal:  Regul Pept       Date:  2006-06-16

6.  Does dietary iodine regulate oxidative stress and adiponectin levels in human breast milk?

Authors:  Carolina Gutiérrez-Repiso; Inés Velasco; Eva Garcia-Escobar; Sara Garcia-Serrano; Francisca Rodríguez-Pacheco; Francisca Linares; Maria Soledad Ruiz de Adana; Elehazara Rubio-Martin; Lourdes Garrido-Sanchez; Juan Francisco Cobos-Bravo; Tatiana Priego-Puga; Gemma Rojo-Martinez; Federico Soriguer; Eduardo García-Fuentes
Journal:  Antioxid Redox Signal       Date:  2013-10-09       Impact factor: 8.401

7.  Obesity and insulin resistance-related changes in the expression of lipogenic and lipolytic genes in morbidly obese subjects.

Authors:  F J Tinahones; L Garrido-Sanchez; M Miranda; J M García-Almeida; M Macias-Gonzalez; V Ceperuelo; E Gluckmann; J Rivas-Marin; J Vendrell; E García-Fuentes
Journal:  Obes Surg       Date:  2010-11       Impact factor: 4.129

8.  Gene expression of the GH receptor in subcutaneous and intraabdominal fat in healthy females: relationship to GH-binding protein.

Authors:  Sanne Fisker; Betina Hansen; Jens Fuglsang; Kurt Kristensen; Per Ovesen; Hans Ørskov; Jens Otto Lunde Jørgensen
Journal:  Eur J Endocrinol       Date:  2004-06       Impact factor: 6.664

9.  Impact of obesity on the growth hormone axis: evidence for a direct inhibitory effect of hyperinsulinemia on pituitary function.

Authors:  Raul M Luque; Rhonda D Kineman
Journal:  Endocrinology       Date:  2006-03-02       Impact factor: 4.736

Review 10.  Tissue-Specific GHR Knockout Mice: Metabolic Phenotypes.

Authors:  Liou Y Sun; Andrzej Bartke
Journal:  Front Endocrinol (Lausanne)       Date:  2015-01-19       Impact factor: 5.555

View more
  1 in total

1.  Tissue-Specific Phenotype and Activation of iNKT Cells in Morbidly Obese Subjects: Interaction with Adipocytes and Effect of Bariatric Surgery.

Authors:  Soledad López; Sara García-Serrano; Carolina Gutierrez-Repiso; Francisca Rodríguez-Pacheco; Ailec Ho-Plagaro; Concepción Santiago-Fernandez; Gonzalo Alba; Marta Cejudo-Guillen; Alberto Rodríguez-Cañete; Sergio Valdes; Lourdes Garrido-Sanchez; David Pozo; Eduardo García-Fuentes
Journal:  Obes Surg       Date:  2018-09       Impact factor: 4.129

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.